This live activity (“American Society for Investigative Pathology [ASIP] 2019 Annual Meeting”) has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society for Clinical Pathology (ASCP) and the American Society for Investigative Pathology (ASIP). ASCP is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this live educational activity (ASIP 2019 Annual Meeting) for a maximum of 32.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The objective of the ASIP 2019 Annual Meeting is to increase basic and applied pathology knowledge, focusing on pathogenesis of disease. The ASIP 2019 Annual Meeting is designed to meet the participants' education needs in the physician competency area of Medical Knowledge, as defined by the Accreditation Council for Graduate Medical Education (ACGME) and the American Board of Medical Specialties (ABMS), and to support participants' lifelong learning towards a goal of promoting patient safety and improving patient care and is specifically targeted to graduate and medical students, pathology residents, post-doctoral fellows, research scientists, clinical practitioners, laboratory professionals, and medical education professionals.
At the completion of the ASIP 2019 Annual Meeting, participants should be able to:
In order to ensure balance, independence, objectivity and scientific rigor in all its educational activities, and in accordance with ACCME Standards, the ASCP requires that all individuals in a position to influence and/or control the content of ASCP CME activities disclose to the ASCP and subsequently to learners whether they do or do not have any relevant financial relationships with proprietary entities producing health care goods or services that are discussed in CME activities. Faculty are asked to use generic names in any discussion of therapeutic options, to base patient care recommendations on scientific evidence and to base information regarding commercial products/services on scientific methods generally accepted by the medical community. All ASCP CME activities are evaluated by participants for the presence of any commercial bias and thus input is used to subsequent CME planning decisions. The primary purpose of this "live" CME activity is educational and the comments, opinions, and/or recommendations expressed by the faculty or authors are their own and not those of ASCP or ASIP.
The ASIP Program Committee members and staff of this CME activity have been asked to disclose any relationships that could be perceived by some as a real or apparent conflict of interest.
None of the organizers of this educational activity disclosed a relevant financial relationship.
Pilar Alcaide
Diane Bielenberg
William Coleman
Piyali Dasgupta
Ivana Delalle
Wen-Xing Ding
Kevin Gardner
Jonathon Homeister
Philip Iannaccone
Andrei Ivanov
Denuja Karunakaran
Themis Kyriakides
Lisa McFadden
Danny Milner
Richard Mitchell
Kari Nejak-Bowen
Asma Nusrat
Jose Otero
Daniel Remick
Douglas Stairs
James Stone
David Sullivan
Elizabeth Whitley
David Williams
Qin Yan
Cecelia Yates
Qing Zhang
All invited faculty of CME-designated sessions have been asked to disclose any relationships that, in the context of their presentation, could be perceived by some as a real or apparent conflict of interest. The following Faculty have indicated relationships that have been reviewed, and their commercial conflicts of interest have been resolved. In all cases, it was determined that the financial relationship did not relate to the educational content of their presentation. If a presenter is not listed, then he/she had no commercial interest to disclose.
Carey Anders, MD, Duke University
Commercial Interest(s): Novartis, Merrimack, PUMA, Lily, Merck, Seattle Genetics, Nektar, Tesaro, G1-Therapeutics<
Role: Study PI
Compensation: Research Funding
Carey Anders, MD, Duke University
Commercial Interest(s): Novartis, Merrimack, Lilly, Merck, Seattle Genetics, Nektar, Merck, PUMA, IPSEN, Eisai, Genentech
Role: Consultant
Compensation: Honorarium
Carey Anders, MD, Duke University
Commercial Interest(s): UpToDate, Jones and Bartlett
Role: Co-Author
Compensation: Royalties
Philip Chen, MD, PhD, Sonic Healthcare
Commercial Interest: Sonic Healthcare
Role: Employee
Compensation: Salary, Stock Options
Philip Chen, MD, PhD, Sonic Healthcare
Commercial Interest(s): Roche Diagnostics/Lab Leaders Forum
Role: Speaker
Compensation: Honorarium, Travel
Gordon Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Commercial Interest(s): Bristol-Myers-Squibb, Roche, Merck, EMD-Serono, Boehringer-Ingelheim, AstraZeneca, Novartis, Dako
Role: DFCI-Administered Patent Licensing Fees and Royalties From Patents on the PD-L1/PD-1 Pathway
Compensation: Financial Considerations
Gordon Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Commercial Interest: Novartis
Role: DFCI-Administered Patent Licensing Fees From Patents on the TIM-3 Pathway
Compensation: Financial Considerations
Gordon Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Commercial Interest: Xios, Origimed
Role: Scientific Advisory Board
Compensation: Financial Considerations
Gordon Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Commercial Interest(s): Surface Oncology, Elstar, SQ2 Biotech, Adaptimmune
Role: Wife on Scientific Advisory Board
Compensation: Financial Considerations
Gordon Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Commercial Interest: Bristol-Myers-Squibb
Role: DFCI-Administered Grant
Compensation: Grant
Gordon Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Commercial Interest(s): Novartis, Roche, UCB, Ipsen, Quark
Role: Wife Sponsored Research Grant
Compensation: Grant
Gordon Freeman, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Commercial Interest: Bristol-Myers-Squibb
Role: Speaker, Consultant
Compensation: Honorarium
Erica Herzog, MD, PhD, Yale School of Medicine
Commercial Interest: Boehringer Ingelheim
Role: Speaker, Consultant
Compensation: Honorarium
Erica Herzog, MD, PhD, Yale School of Medicine
Commercial Interest(s): Genentech, Merck
Role: Consultant
Compensation: Consultancy Fees
A. John Iafrate, MD, Harvard Medical School
Commercial Interest: ArcherDx
Role: Founder
Compensation: Equity
A. John Iafrate, MD, Harvard Medical School
Commercial Interest: Sanofi
Role: Research PI
Compensation: Research Funds
A. John Iafrate, MD, Harvard Medical School
Commercial Interest: Roche
Role: Consultant
Compensation: Consultancy Fee
Javid Moslehi, MD, PhD, Vanderbilt University
Commercial Interest(s): Bristol-Myers Squibb, Pfizer, Novartis, Takeda, IPSEN
Role: Advisory Board
Compensation: Honorarium
Don Rockey, MD, Medical University of South Carolina
Commercial Interest(s): NIH/NIDDK, Ironwood Pharmaceuticals, Actelion Pharmaceuticals
Role: PI
Compensation: Research Grants
Don Rockey, MD, Medical University of South Carolina
Commercial Interest(s): Galectin Pharma, Gilead Sciences, Connatus Pharmaceuticals, Cumberland Pharmaceuticals, Intercept Pharmaceuticals, Mallinckrodt Pharmaceuticals, Shire
Role: Site PI
Compensation: Research Grants
Yang Shi, PhD, Boston Children’s Hospital
Commercial Interest(s): Constellation Pharmaceuticals, Athelas Therapeutics
Role: Co-Founder
Compensation: Equity
Yang Shi, PhD, Boston Children’s Hospital
Commercial Interest(s): Active Motif, 6D Capital
Role: Equity, Consultant
Compensation: Equity, Consultancy Fees
Janis Marie Taube, MD, MSc, Johns Hopkins University
Commercial Interest(s): Bristol-Myers Squibb, Merck, Astra Zeneca
Role: Advisory Board Consultant
Compensation: Honorarium
Janis Marie Taube, MD, MSc, Johns Hopkins University
Commercial Interest: Bristol-Myers Squibb
Role: Investigator
Compensation: Research Funding
Janis Marie Taube, MD, MSc, Johns Hopkins University
Commercial Interest: Akoya Biosciences
Role: Researcher (Collaborator)
Compensation: Loan of Vectra Machine and Reagents
Kevin Tracey, MD, Zucker School of Medicine
Commercial Interest: Set Point Medical
Role: Consultant
Compensation: Consultancy Fee
Wenyi Wei, PhD, Beth Israel Deaconess Medical Center/Harvard Medical School
Commercial Interest: Rekindle Therapeutics
Role: Scientific Co-Founder
Compensation: Consultancy Fee
Please note that the only Society educational component of Experimental Biology 2019 that is eligible for CME credit is the ASIP 2019 Annual Meeting.
This ASIP 2019 Annual Meeting CME Workbook includes a consolidated list of ASIP scientific sessions that are eligible for AMA PRA Category 1 Credit(s)™. The Workbook will be available in the ASIP Office Office located in the Orange County Convention Center (Room W-103AB) and online on the ASIP Meeting website (http://asip19.asip.org/) In addition, signage outside of the ASIP meeting rooms will designate those educational sessions that are eligible for AMA PRA Category 1 Credit(s)™. Please also be aware that visiting exhibits and posters in the exhibit hall is not an approved continuing medical education activity because of ACCME standards that are designed to prevent commercial bias.
CME Application Forms can be found on the ASIP Meeting website (http://asip19.asip.org/) beginning April 10, 2019. Applications for CME credit must be submitted online no later than June 1, 2019. You will receive your CME certificate within one week from submission of your online application. If you have questions concerning your CME application (or do not receive your certificate within the timeframe explained above), contact the ASIP Education Office by phone (240) 283-9712, email cme@asip.org or write to ASIP Education Office, 1801 Rockville Pike, Suite 350, Rockville, MD 20852.